Dinari Bristol-Myers Squibb Co.BMY
Dinari Bristol-Myers Squibb Co. (BMY) is a token tracking BMY shares, backed by dedicated collateral, issued by Dinari through Dinari, Inc., and distributed through Dinari, Inc. with Dinari Securities, LLC as broker. The underlying security is listed in the health care sector in North America. Each token tracks one underlying share, entitles holders to dividends, which are distributed in cash, and carries no voting rights. The collateral assets are held by Alpaca Securities LLC in accounts segregated from the issuer's own funds. Residents of the United States, Canada, jurisdictions under applicable sanctions and other jurisdictions the issuer restricts cannot mint or redeem with Dinari. Dinari, Inc. is incorporated in the United States and is offered under an SEC Regulation S exemption. Holder terms are governed by the law of Delaware in the United States. BMY has been issued on public blockchains since August 2026 and is native to Arbitrum One, Avalanche, Base, and Ethereum.